Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Practical considerations for choosing a mouse model of Alzheimer’s disease
Joanna L. Jankowsky, Hui Zheng
Molecular Neurodegeneration (2017) Vol. 12, Iss. 1
Open Access | Times Cited: 375

Showing 1-25 of 375 citing articles:

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis
Phuong H. Nguyen, Ayyalusamy Ramamoorthy, Bikash R. Sahoo, et al.
Chemical Reviews (2021) Vol. 121, Iss. 4, pp. 2545-2647
Open Access | Times Cited: 538
Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease
Ethan R. Roy, Baiping Wang, Ying‐Wooi Wan, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 4, pp. 1912-1930
Open Access | Times Cited: 390
Meta-Analysis of the Alzheimer’s Disease Human Brain Transcriptome and Functional Dissection in Mouse Models
Ying‐Wooi Wan, Rami Al‐Ouran, Carl Grant Mangleburg, et al.
Cell Reports (2020) Vol. 32, Iss. 2, pp. 107908-107908
Open Access | Times Cited: 251
Alzheimer’s Disease: Treatment Strategies and Their Limitations
Elodie Passeri, Kamil Elkhoury, Margaretha Morsink, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13954-13954
Open Access | Times Cited: 250
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study
Adrian L. Oblak, Peter Bor‐Chian Lin, Kevin P. Kotredes, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 219
Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies
Che-Wei Chang, Qiang Shao, Lennart Mucke
Science (2021) Vol. 371, Iss. 6532
Open Access | Times Cited: 189
Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation
Takashi Saito, Naomi Mihira, Yukio Matsuba, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 34, pp. 12754-12765
Open Access | Times Cited: 177
APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
Zonghua Li, Francis Shue, Na Zhao, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 169
Microglia in Brain Development, Homeostasis, and Neurodegeneration
Christopher J. Bohlen, Brad A. Friedman, Borislav Dejanovic, et al.
Annual Review of Genetics (2019) Vol. 53, Iss. 1, pp. 263-288
Open Access | Times Cited: 165
Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression
Yu Yamazaki, Mitsuru Shinohara, Motoko Shinohara, et al.
Brain (2019) Vol. 142, Iss. 4, pp. 1077-1092
Open Access | Times Cited: 148
Traumatic Brain Injury Induces Tau Aggregation and Spreading
George A. Edwards, Jing Zhao, Pramod K. Dash, et al.
Journal of Neurotrauma (2019) Vol. 37, Iss. 1, pp. 80-92
Open Access | Times Cited: 148
Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Raquel Sánchez‐Varo, Marina Mejias‐Ortega, Juan José Fernandez-Valenzuela, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5404-5404
Open Access | Times Cited: 80
Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia
Dan Xia, Steve Lianoglou, Thomas Sandmann, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 71
Microglia regulation of central nervous system myelin health and regeneration
Sarah Kent, Véronique E. Miron
Nature reviews. Immunology (2023) Vol. 24, Iss. 1, pp. 49-63
Closed Access | Times Cited: 60
Updates on mouse models of Alzheimer’s disease
Michael Z Zhong, Thomas Peng, Mariana Lemos Duarte, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 42
Neuropathogenesis-on-chips for neurodegenerative diseases
Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 25
Gut microbiota-driven metabolic alterations reveal gut–brain communication in Alzheimer’s disease model mice
Yijing Chen, Yinhu Li, Yingying Fan, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 19
Behaviour Hallmarks in Alzheimer’s Disease 5xFAD Mouse Model
Mafalda Soares Pádua, José Luis Guil‐Guerrero, Paula A. Lopes
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6766-6766
Open Access | Times Cited: 15
Human and mouse proteomics reveals the shared pathways in Alzheimer’s disease and delayed protein turnover in the amyloidome
Jay M. Yarbro, Xian Han, Abhijit Dasgupta, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Intracerebral Injection of Extracellular Vesicles from Mesenchymal Stem Cells Exerts Reduced Aβ Plaque Burden in Early Stages of a Preclinical Model of Alzheimer’s Disease
Chiara Elia, Matteo Tamborini, Marco Rasile, et al.
Cells (2019) Vol. 8, Iss. 9, pp. 1059-1059
Open Access | Times Cited: 108
Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau
Sruti Rayaprolu, Lenora Higginbotham, Pritha Bagchi, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 1, pp. 98-115
Open Access | Times Cited: 100
Neuroinflammation in mouse models of Alzheimer's disease
Takashi Saito, Takaomi C. Saido
Clinical and Experimental Neuroimmunology (2018) Vol. 9, Iss. 4, pp. 211-218
Open Access | Times Cited: 99
Genetic architecture of Alzheimer's disease
Sarah M. Neuner, Julia TCW, Alison Goate
Neurobiology of Disease (2020) Vol. 143, pp. 104976-104976
Open Access | Times Cited: 99
Leveraging preclinical models for the development of Alzheimer disease therapeutics
Kimberly Scearce‐Levie, Pascal E. Sanchez, Joseph W. Lewcock
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 7, pp. 447-462
Closed Access | Times Cited: 97
Amyloid-β: a potential link between epilepsy and cognitive decline
Michele Romoli, Arjune Sen, Lucilla Parnetti, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 8, pp. 469-485
Closed Access | Times Cited: 94
Page 1 - Next Page

Scroll to top